tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Technical Analysis

Compare
576 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 1.92, suggesting Ascendis Pharma is a Buy.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 160.55, while Ascendis Pharma’s (ASND) share price is $151.25, making it a Sell.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 155.50, while Ascendis Pharma’s (ASND) share price is $151.25, making it a Sell.

Ascendis Pharma (ASND) Pivot Points

May 12, 2025, 01:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
149.35
152.68
156.04
159.37
162.73
166.06
169.42
Fibonacci
152.68
155.24
156.82
159.37
161.93
163.51
166.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

May 12, 2025, 01:26 PM
Period
Simple
Exponential
MA5
161.04Sell
159.18Sell
MA10
164.66Sell
161.42Sell
MA20
161.66Sell
160.55Sell
MA50
156.49Sell
155.50Sell
MA100
146.06Buy
149.00Buy
MA200
139.17Buy
142.41Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 161.42, while Ascendis Pharma’s (ASND) share price is $151.25, making it a Sell.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 149.00, while Ascendis Pharma’s (ASND) share price is $151.25, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $151.25 and Ascendis Pharma’s (ASND) 50-day simple moving average is 156.49, creating a Sell signal.
Ascendis Pharma’s (ASND) stock price is $151.25 and Ascendis Pharma’s (ASND) 100-day simple moving average is 146.06, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $151.25 and Ascendis Pharma’s (ASND) 200-day simple moving average is 139.17, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

May 12, 2025, 01:26 PM
Name
Value
Implied Action
RSI (14)
41.32
Neutral
STOCH (9,6)
8.69
Buy
STOCHRSI (14)
15.84
Buy
MACD (12,26)
1.92
Buy
ADX (14)
17.43
Buy
Williams %R
-99.56
Buy
CCI (14)
-93.90
Neutral
ATR (14)
8.42
-
Ultimate Oscillator
32.50
Neutral
ROC
-6.14
Sell
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 41.32, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 17.43, creating a Buy signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is -93.90, creating a Neutral signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is -6.14, creating a Sell signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Hold.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 41.32, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 1.92, which suggests ASND is a Buy.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 161.04, which suggests ASND is a Sell.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 161.66, which suggests ASND is a Sell.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 156.49, which suggests ASND is a Sell.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 139.17, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -99.56, which suggests ASND is a Buy.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is -93.90, which suggests ASND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis